<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36715782</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Clinical relevance of macroglossia to disease progression in ventilation dependent patients with advanced ALS.</ArticleTitle><Pagination><StartPage>2025</StartPage><EndPage>2031</EndPage><MedlinePgn>2025-2031</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-023-06646-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Macroglossia is one of the clinical signs that emerges in patients with amyotrophic lateral sclerosis (ALS) who are undergoing invasive ventilation.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to investigate the relationship between the progression of macroglossia and the clinical characteristics during the advanced stages of ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Forty-one patients with ALS using invasive ventilation with tracheostomy were prospectively followed over a 3-year period. We evaluated the prevalence of macroglossia, motor disabilities including oral function, communication ability (communication stage I to V) as a marker of disease progression, and nutritional factors. We analyzed the potential factors affecting the progression of macroglossia using a multivariate logistic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of patients with macroglossia was increased during the follow-up (from 24.4 to 53.7%), while the communication stage progressed from 2.6 in average (SD 1.7) to 3.5 (1.4). During the study, body weight increased, while energy intake decreased, suggesting progressive hypometabolism. Eight patients had newly developed macroglossia during the study and showed greater progression of communication impairment than those without macroglossia. Multivariate logistic regression analysis showed that communication impairment was a factor associated with macroglossia.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Macroglossia in advanced ALS with invasive ventilation is associated with disease progression.</AbstractText><CopyrightInformation>&#xa9; 2023. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Chiharu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9209-6094</Identifier><AffiliationInfo><Affiliation>Unit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3828-9669</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1 Musashidai, Fuchu, Tokyo, 183-0042, Japan. toshio_shimizu@tmhp.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8620-612X</Identifier><AffiliationInfo><Affiliation>Unit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haraguchi</LastName><ForeName>Michiko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit for Intractable Disease Nursing Care, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hakuta</LastName><ForeName>Chiyoko</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oral Health Sciences for Community Welfare, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hidaka</LastName><ForeName>Rena</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4998-6275</Identifier><AffiliationInfo><Affiliation>Department of Oral Health Sciences for Community Welfare, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishiyama</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orofacial Pain Management, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Numayama</LastName><ForeName>Takaya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3590-0653</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Sayama Neurological Hospital, Saitama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>16K12054</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>19K10896</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C531735">Congenital macroglossia</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008260" MajorTopicYN="Y">Macroglossia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000092522" MajorTopicYN="N">Clinical Relevance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">Communication impairment</Keyword><Keyword MajorTopicYN="N">Invasive ventilation</Keyword><Keyword MajorTopicYN="N">Macroglossia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>30</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36715782</ArticleId><ArticleId IdType="doi">10.1007/s10072-023-06646-7</ArticleId><ArticleId IdType="pii">10.1007/s10072-023-06646-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiss LS, White JA (1990) Macroglossia: a review. J La State Med Soc. 142(8):13&#x2013;16</Citation><ArticleIdList><ArticleId IdType="pubmed">2230521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar BC, Prabhakar T, Manrai KP, Rawat GS (2001) Macroglossia: a rare clinical entity. Med J Armed Forces India. 57(2):169&#x2013;171. https://doi.org/10.1016/S0377-1237(01)80147-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0377-1237(01)80147-7</ArticleId><ArticleId IdType="pubmed">27407330</ArticleId><ArticleId IdType="pmc">4925850</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda C, Shimizu T, Nakayama Y et al (2016) Macroglossia in advanced amyotrophic lateral sclerosis. Muscle Nerve. 54(3):386&#x2013;390. https://doi.org/10.1002/mus.25058</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25058</ArticleId><ArticleId IdType="pubmed">26816340</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Matsuda C et al (2018) Non-motor manifestations in ALS patients with tracheostomy and invasive ventilation. Muscle Nerve. 57(5):735&#x2013;741. https://doi.org/10.1002/mus.26004</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26004</ArticleId><ArticleId IdType="pubmed">29105161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi N, Atsuta N, Yokoi D et al (2020) Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J Neurol Neurosurg Psychiatry. 91(3):285&#x2013;290. https://doi.org/10.1136/jnnp-2019-322213</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322213</ArticleId><ArticleId IdType="pubmed">31937581</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Mochizuki Y et al (2016) Predictors of impaired communication in amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. Amyotroph Lateral Scler Frontotemporal Degener. 17(1&#x2013;2):38&#x2013;46. https://doi.org/10.3109/21678421.2015.1055276</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1055276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami M, Kimura F, Nakajima H et al (2014) Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990&#x2013;2010. J Neurol Sci. 344(1&#x2013;2):158&#x2013;164. https://doi.org/10.1016/j.jns.2014.06.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.06.047</ArticleId><ArticleId IdType="pubmed">25017882</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee HR, Escott E, Damm D, Kasarskis E (2013) Macroglossia in amyotrophic lateral sclerosis. JAMA Neurol. 70(11):1432&#x2013;1435. https://doi.org/10.1001/jamaneurol.2013.3138</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3138</ArticleId><ArticleId IdType="pubmed">24042440</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1(5):293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 131(8):1975&#x2013;1978. https://doi.org/10.1016/j.clinph.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 169(1&#x2013;2):13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, Mochizuki Y, Nakayama Y et al (2013) Communication disorder in amyotrophic lateral sclerosis after ventilation&#x2013;a proposal of staging and a study of predictive factor. Rinsho Shinkeigaku. 53(2):98&#x2013;103</Citation><ArticleIdList><ArticleId IdType="doi">10.5692/clinicalneurol.53.98</ArticleId><ArticleId IdType="pubmed">23470888</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Matsuda C et al (2019) Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci Rep. 9(1):12262. https://doi.org/10.1038/s41598-019-48831-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48831-9</ArticleId><ArticleId IdType="pubmed">31439899</ArticleId><ArticleId IdType="pmc">6706382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Oppenheimer EA (2003) ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications. Neurology. 61(1):135&#x2013;137</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000069925.02052.1F</ArticleId><ArticleId IdType="pubmed">12847177</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris FH Jr, Calanchini PR, Fallat RJ, Panchari S, Jewett B (1974) The administration of guanidine in amyotrophic lateral sclerosis. Neurology. 24(8):721&#x2013;728</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.24.8.721</ArticleId><ArticleId IdType="pubmed">4858705</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda E, Ohashi Y, Tashiro K, Mizuno Y, Kowa H, Yanagisawa N (1996) Reliability and factorial structure of a rating scale for amyotrophic lateral sclerosis. No To Shinkei. 48(11):999&#x2013;1007</Citation><ArticleIdList><ArticleId IdType="pubmed">8951891</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama Y, Shimizu T, Matsuda C et al (2022) Body weight gain is associated with the disease stage in advanced amyotrophic lateral sclerosis with invasive ventilation. Metabolites. 12(2):191. https://doi.org/10.3390/metabo12020191</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12020191</ArticleId><ArticleId IdType="pubmed">35208264</ArticleId><ArticleId IdType="pmc">8874426</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Peter RS, Rosenbohm A et al (2017) Adipokines, C-reactive protein and amyotrophic lateral sclerosis &#x2013; results from a population-based ALS registry in Germany. Sci Rep. 7(1):4374. https://doi.org/10.1038/s41598-017-04706-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04706-5</ArticleId><ArticleId IdType="pubmed">28663573</ArticleId><ArticleId IdType="pmc">5491500</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JY, Cui LY, Sun XH et al (2022) Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 9(7):1027&#x2013;1038. https://doi.org/10.1002/acn3.51580</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51580</ArticleId><ArticleId IdType="pubmed">35584112</ArticleId><ArticleId IdType="pmc">9268864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaoka U, Shimizu T, Uchihara T et al (2022) Decreased plasma ghrelin in male ALS patients is associated with poor prognosis. Neurosci Res. 177:111&#x2013;117. https://doi.org/10.1016/j.neures.2021.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2021.11.003</ArticleId><ArticleId IdType="pubmed">34823917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo M, Jesus P, Lizio A et al (2022) The hypometabolic state: a good predictor of a better prognosis in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 93(1):41&#x2013;47. https://doi.org/10.1136/jnnp-2021-326184</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-326184</ArticleId><ArticleId IdType="pubmed">34353859</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Fu J, Zhao W et al (2022) Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis. J Neurol. 269(3):1447&#x2013;1455. https://doi.org/10.1007/s00415-021-10716-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10716-1</ArticleId><ArticleId IdType="pubmed">34274994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichihara N, Namba K, Ishikawa-Takata K et al (2012) Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation. Amyotroph Lateral Scler. 13(6):544&#x2013;549. https://doi.org/10.3109/17482968.2012.699968</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.699968</ArticleId><ArticleId IdType="pubmed">22889175</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Hayashi H, Tanabe H (1991) Energy metabolism of ALS patients under mechanical ventilation and tube feeding. Rinsho Shinkeigaku. 31(3):255&#x2013;259</Citation><ArticleIdList><ArticleId IdType="pubmed">1909943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama Y, Abe K, Tokunaga J, Numayama T (2019) Metabolic syndrome in advanced amyotrophic lateral sclerosis patients with tracheostomy-invasive ventilation. Neurol Clin Neurosci. 7(4):174&#x2013;179. https://doi.org/10.1111/ncn3.12289</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12289</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, Mochizuki Y, Takeuchi R et al (2016) Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V). Acta Neuropathol Commun. 4(1):107. https://doi.org/10.1186/s40478-016-0379-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0379-3</ArticleId><ArticleId IdType="pubmed">27716404</ArticleId><ArticleId IdType="pmc">5045653</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K, Mochizuki Y, Nakayama Y et al (2015) Marked preservation of the visual and olfactory pathways in ALS patients in a totally locked-in state. Clin Neuropathol. 34(5):267&#x2013;274. https://doi.org/10.5414/NP300859</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300859</ArticleId><ArticleId IdType="pubmed">26042590</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ (2014) TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2:171. https://doi.org/10.1186/s40478-014-0171-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0171-1</ArticleId><ArticleId IdType="pubmed">25539830</ArticleId><ArticleId IdType="pmc">4297460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabery S, Ahmed RM, Caga J, Kiernan MC, Halliday GM, Petersen A (2021) Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 47(7):979&#x2013;989. https://doi.org/10.1111/nan.12709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12709</ArticleId><ArticleId IdType="pubmed">33755993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M, Vercruysse P, Muller HP et al (2017) Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 88(12):1033&#x2013;1041. https://doi.org/10.1136/jnnp-2017-315795</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Ren Q, Gong G et al (2022) Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis. J Neurol. 269(6):2980&#x2013;2988. https://doi.org/10.1007/s00415-021-10900-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10900-3</ArticleId><ArticleId IdType="pubmed">34779889</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M et al (2009) Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 276(1&#x2013;2):163&#x2013;169. https://doi.org/10.1016/j.jns.2008.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.09.024</ArticleId><ArticleId IdType="pubmed">18962725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>